The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
CD3-specific antibodies: a portal to the treatment of autoimmunity
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition
Genovese, M. C., Becker, J.-C., Schiff, M., Luggen, M., Sherrer, Y., Kremer, J., Birbara, C., Box, J., Natarajan, K., Nuamah, I., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050524 · Cited by 1,241
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
Self-citationSpreading of T-cell autoimmunity to cryptic determinants of an autoantigen
Lehmann, P. V., Forsthuber, T., Miller, A., & Sercarz, E. E. (1992) · Nature · doi:10.1038/358155a0 · Cited by 1,186
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043980 · Cited by 1,099
Self-citationKaufman, D. L., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G. S. P., Robinson, P., Atkinson, M. A., Sercarz, E. E., Tobin, A. J., & Lehmann, P. V. (1993) · Nature · doi:10.1038/366069a0 · Cited by 1,070
Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease
Van Assche, G., Van Ranst, M., Sciot, R., Dubois, B., Vermeire, S., Noman, M., Verbeeck, J., Geboes, K., Robberecht, W., & Rutgeerts, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051586 · Cited by 1,060
Kremer, J. M., Westhovens, R., Leon, M., Di Giorgio, E., Alten, R., Steinfeld, S., Russell, A., Dougados, M., Emery, P., Nuamah, I. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035075 · Cited by 1,058
Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
Langer-Gould, A., Atlas, S. W., Green, A. J., Bollen, A. W., & Pelletier, D. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051847 · Cited by 1,034
Gómez‐Reino, J. J., Carmona, L., Valverde, V. R., Mola, E. M., & Montero, M. D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11137 · Cited by 1,013
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
Tisch, R., Yang, X.-D., Singer, S. M., Liblau, R. S., Fugger, L., & McDevitt, H. O. (1993) · Nature · doi:10.1038/366072a0 · Cited by 949
Strategies to Improve Long-Term Outcomes after Renal Transplantation
Pascual, M., Theruvath, T., Kawai, T., Tolkoff-Rubin, N., & Cosimi, A. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011295 · Cited by 844
Effects of insulin in relatives of patients with type 1 diabetes mellitus
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012350 · Cited by 836
Li, Y., Li, X. C., Zheng, X. X., Wells, A. D., Turka, L. A., & Strom, T. B. (1999) · Nature Medicine · doi:10.1038/15256 · Cited by 745
Battaglia, M., Stabilini, A., Migliavacca, B., Horejs-Hoeck, J., Kaupper, T., & Roncarolo, M.-G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8338 · Cited by 736
β-Cell Failure in Diabetes and Preservation by Clinical Treatment
Wajchenberg, B. L. (2007) · Endocrine Reviews · doi:10.1210/10.1210/er.2006-0038 · Cited by 714
Khoury, S. J., Hancock, W. W., & Weiner, H. L. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.5.1355 · Cited by 708
Development of anti-TNF therapy for rheumatoid arthritis
Feldmann, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri802 · Cited by 673
Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
Chatenoud, L., Thervet, E., Primo, J., & Bach, J. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.123 · Cited by 664
Self-citationHerold, K. C., Gitelman, S. E., Masharani, U., Hagopian, W., Bisikirska, B., Donaldson, D., Rother, K., Diamond, B., Harlan, D. M., & Bluestone, J. A. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1763 · Cited by 634
Self-citationCTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
Abrams, J. R., Lebwohl, M. G., Guzzo, C. A., Jegasothy, B. V., Goldfarb, M. T., Goffe, B. S., Menter, A., Lowe, N. J., Krueger, G., Brown, M. J., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5857 · Cited by 597
Belghith, M., Bluestone, J. A., Barriot, S., Mégret, J., Bach, J.-F., & Chatenoud, L. (2003) · Nature Medicine · doi:10.1038/nm924 · Cited by 586
Self-citationPersistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading
Miller, S. D., Vanderlugt, C. L., Begolka, W. S., Pao, W., Yauch, R. L., Neville, K. L., Katz-Levy, Y., Carrizosa, A., & Kim, B. S. (1997) · Nature Medicine · doi:10.1038/nm1097-1133 · Cited by 565
Dendritic cells: emerging pharmacological targets of immunosuppressive drugs
Hackstein, H., & Thomson, A. W. (2004) · Nature Reviews Immunology · doi:10.1038/nri1256 · Cited by 545
Feutren, G., Assan, R., Karsenty, G., Du Rostu, H., Sirmai, J., Papoz, L., Vialettes, B., Vexiau, P., Rodier, M., Lallemand, A., et al. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91943-4 · Cited by 448
Kremer, J. M., Dougados, M., Emery, P., Durez, P., Sibilia, J., Shergy, W., Steinfeld, S., Tindall, E., Becker, J., Li, T., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21201 · Cited by 444
Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M. K., & Adorini, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.817 · Cited by 423
CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice
Chatenoud, L., Primo, J., & Bach, J. F. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2947 · Cited by 417
Self-citationMaintenance of Human T Cell Anergy: Blocking of IL-2 Gene Transcription by Activated Rap1
Boussiotis, V. A., Freeman, G. J., Berezovskaya, A., Barber, D. L., & Nadler, L. M. (1997) · Science · doi:10.1126/science.278.5335.124 · Cited by 409
Daniel, D., & Wegmann, D. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.956 · Cited by 406
The mechanisms, diagnosis, and management of severe asthma in adults
Holgate, S. T., & Polosa, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69288-x · Cited by 398
Fleischmann, R. M., Schechtman, J., Bennett, R., Handel, M. L., Burmester, G., Tesser, J., Modafferi, D., Poulakos, J., & Sun, G. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10870 · Cited by 392
Hering, B. J., Kandaswamy, R., Harmon, J. V., Ansite, J. D., Clemmings, S. M., Sakai, T., Paraskevas, S., Eckman, P. M., Sageshima, J., Nakano, M., et al. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00351.x · Cited by 367
Self-citationABRAMOWICZ, D., SCHANDENE, L., GOLDMAN, M., CRUSIAUX, A., VEREERSTRAETEN, P., PAUW, L. D., WYBRAN, J., KINNAERT, P., DUPONT, E., & TOUSSAINT, C. (1989) · Transplantation · doi:10.1097/00007890-198904000-00008 · Cited by 352
Bisikirska, B., Colgan, J., Luban, J., Bluestone, J. A., & Herold, K. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23961 · Cited by 339
Self-citationCHATENOUD, L., FERRAN, C., LEGENDRE, C., THOUARD, I., MERITE, S., REUTER, A., GEVAERT, Y., KREIS, H., FRANCHIMONT, P., & BACH, J.-F. (1990) · Transplantation · doi:10.1097/00007890-199004000-00009 · Cited by 320
Self-citationAbrams, J. R., Kelley, S. L., Hayes, E., Kikuchi, T., Brown, M. J., Kang, S., Lebwohl, M. G., Guzzo, C. A., Jegasothy, B. V., Linsley, P. S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.681 · Cited by 318
Aerosol Insulin Induces Regulatory CD8 γδ T Cells That Prevent Murine Insulin-dependent Diabetes
Harrison, L. C., Dempsey-Collier, M., Kramer, D. R., & Takahashi, K. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2167 · Cited by 310
CD3-specific antibody-induced active tolerance: from bench to bedside
Chatenoud, L. (2003) · Nature Reviews Immunology · doi:10.1038/nri1000 · Cited by 309
Self-citationInsulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy
Atkinson, M. A., Maclaren, N. K., & Luchetta, R. (1990) · Diabetes · doi:10.2337/diab.39.8.933 · Cited by 299
Bresson, D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27191 · Cited by 293
Nussenblatt, R. B., Caspi, R. R., Mahdi, R., Chan, C. C., Roberge, F., Lider, O., & Weiner, H. L. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.5.1689 · Cited by 281
CTLA4Ig: Bridging the Basic Immunology with Clinical Application
Bluestone, J. A., St. Clair, E. W., & Turka, L. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.001 · Cited by 276
Self-citationMetzler, B., & Wraith, D. C. (1993) · International Immunology · doi:10.1093/intimm/5.9.1159 · Cited by 275
(1989) · New England Journal of Medicine · doi:10.1056/nejm198905253202117 · Cited by 269
Ferran, C., Sheehan, K., Dy, M., Schreiber, R., Merite, S., Landais, P., Noel, L., Grau, G., Bluestone, J., Bach, J., et al. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200308 · Cited by 264
Self-citationPrevention of diabetes in NOD mice treated with antibody to murine IFNγ
Debray-Sachs, M., Carnaud, C., Boitard, C., Cohen, H., Gresser, I., Bedossa, P., & Bach, J.-F. (1991) · Journal of Autoimmunity · doi:10.1016/0896-8411(91)90021-4 · Cited by 258
Chaillous, L., Lefèvre, H., Thivolet, C., Boitard, C., Lahlou, N., Atlan-Gepner, C., Bouhanick, B., Mogenet, A., Nicolino, M., Carel, J.-C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02579-4 · Cited by 248
In Vitro Characterization of Five Humanized OKT3 Effector Function Variant Antibodies
Xu, D., Alegre, M.-L., Varga, S. S., Rothermel, A. L., Collins, A. M., Pulito, V. L., Hanna, L. S., Dolan, K. P., Parren, P. W. H. I., Bluestone, J. A., et al. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1617 · Cited by 238
Self-citationOral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25−LAP+ T cells
Ochi, H., Abraham, M., Ishikawa, H., Frenkel, D., Yang, K., Basso, A. S., Wu, H., Chen, M.-L., Gandhi, R., Miller, A., et al. (2006) · Nature Medicine · doi:10.1038/nm1408 · Cited by 236
Nuki, G., Bresnihan, B., Bear, M. B., & McCabe, D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10578 · Cited by 222
Bolt, S., Routledge, E., Lloyd, I., Chatenoud, L., Pope, H., Gorman, S. D., Clark, M., & Waldmann, H. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230216 · Cited by 218
Self-citationHuman in vivo antigenic modulation induced by the anti‐T cell OKT3 monoclonal antibody
Chatenoud, L., Baudrihaye, M. F., Kreis, H., Goldstein, G., Schindler, J., & Bach, J. (1982) · European Journal of Immunology · doi:10.1002/eji.1830121116 · Cited by 201
Self-citationPeptide therapy for diabetes in NOD mice
Elias, D., & Cohen, I. R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91582-2 · Cited by 198
Valmori, D., Tosello, V., Souleimanian, N. E., Godefroy, E., Scotto, L., Wang, Y., & Ayyoub, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.944 · Cited by 196
Sreenan, S., Pick, A. J., Levisetti, M., Baldwin, A. C., Pugh, W., & Polonsky, K. S. (1999) · Diabetes · doi:10.2337/diabetes.48.5.989 · Cited by 193
Smith, J. A., Tso, J. Y., Clark, M. R., Cole, M. S., & Bluestone, J. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.8.1413 · Cited by 192
Self-citationWoodle, E. S., Xu, D., Zivin, R. A., Auger, J., Charette, J., O'Laughlin, R., Peace, D., Jolliffe, L. K., Haverty, T., Bluestone, J. A., et al. (1999) · Transplantation · doi:10.1097/00007890-199909150-00003 · Cited by 188
Self-citationYou, S., Leforban, B., Garcia, C., Bach, J.-F., Bluestone, J. A., & Chatenoud, L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701171104 · Cited by 180
Self-citationActivation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3γ1(Ala-Ala)
Herold, K. C., Burton, J. B., Francois, F., Poumian-Ruiz, E., Glandt, M., & Bluestone, J. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16090 · Cited by 177
Self-citationCarpenter, P. A., Appelbaum, F. R., Corey, L., Deeg, H. J., Doney, K., Gooley, T., Krueger, J., Martin, P., Pavlovic, S., Sanders, J., et al. (2002) · Blood · doi:10.1182/blood.v99.8.2712 · Cited by 172
Cure of Overt Diabetes in NOD Mice by Transient Treatment With Anti-Lymphocyte Serum and Exendin-4
Ogawa, N., List, J. F., Habener, J. F., & Maki, T. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1700 · Cited by 155
Nicolls, M. R., Aversa, G., PEARCE, N. W., SPINELLI, A., Berger, M. F., Gurley, K. E., & Hall, B. M. (1993) · Transplantation · doi:10.1097/00007890-199303000-00001 · Cited by 145
Kohm, A. P., Williams, J. S., Bickford, A. L., McMahon, J. S., Chatenoud, L., Bach, J., Bluestone, J. A., & Miller, S. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4525 · Cited by 145
Self-citationPHASE I STUDY OF AN ENGINEERED AGLYCOSYLATED HUMANIZED CD3 ANTIBODY IN RENAL TRANSPLANT REJECTION1
Friend, P. J., Hale, G., Chatenoud, L., Rebello, P., Bradley, J. R., Thiru, S. S., Phillips, J. M., & Waldmann, H. (1999) · Transplantation · doi:10.1097/00007890-199912150-00005 · Cited by 145
Self-citationThe evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation
Magliocca, J. F., & Knechtle, S. J. (2006) · Transplant International · doi:10.1111/j.1432-2277.2006.00343.x · Cited by 140
Determinant Spreading of T Helper Cell 2 (Th2) Responses to Pancreatic Islet Autoantigens
Tian, J., Lehmann, P., & Kaufman, D. L. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2039 · Cited by 134
Rabinovitch, A., Suarez‐Pinzon, W. L., Shapiro, A. M. J., Rajotte, R. V., & Power, R. F. (2002) · Diabetes · doi:10.2337/diabetes.51.3.638 · Cited by 134
Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.
Utset, T. O., Auger, J., Peace, D., Zivin, R. A., Xu, D., Jolliffe, L. K., Alegre, M., Bluestone, J. A., & Clark, M. R. (2002) · PubMed · Cited by 131
Self-citationThe European Nicotinamide Diabetes Intervention Trial (ENDIT) Group, Bingley, P. J., & Gale, E. A. M. (2006) · Diabetologia · doi:10.1007/s00125-006-0160-4 · Cited by 112
Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis
Khare, S. D., Krco, C. J., Griffiths, M. M., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.7.3653 · Cited by 104
Smith, J. A., Tang, Q., & Bluestone, J. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4841 · Cited by 101
Self-citationAlegre, M., Vandenabeele, P., Flamand, V., Moser, M., Léo, O., Abramowicz, D., Urbain, J., Fiers, W., & Goldman, M. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200337 · Cited by 82
Charpentier, B., HIESSE, C., Lantz, O. J., Ferran, C. J., Stephens, S., OʼSHAUGNESSY, D., Bodmer, M., Benoît, G., Bach, J., & Chatenoud, L. (1992) · Transplantation · doi:10.1097/00007890-199212000-00011 · Cited by 78
Self-citationMetabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice.
Karounos, D. G., Bryson, J. S., & Cohen, D. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119654 · Cited by 77
Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.
Ferran, C. J., Dautry, F., Merite, S., Sheehan, K. C. F., Schreiber, R. D., Grau, G. E., Bach, J., & Chatenoud, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117215 · Cited by 77
Self-citationPlain, K. M., Chen, J., Merten, S. L., He, X. Y., & Hall, B. M. (1999) · Transplantation · doi:10.1097/00007890-199902270-00020 · Cited by 76
Oral Insulin Therapy to Prevent Progression of Immune‐Mediated (Type 1) Diabetes
Ergun-Longmire, B., Marker, J., Zeidler, A., Rapaport, R., Raskin, P., Bode, B. W., Schatz, D., Vargas, A., Rogers, D. G., Schwartz, S. L., et al. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1309.057 · Cited by 70
Kolarich, D., Turecek, P. L., Weber, A., Mitterer, A., Graninger, M., Matthiessen, P., Nicolaes, G. A. F., Altmann, F., & Schwarz, H. P. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.01004.x · Cited by 70
You, S., Thiéblemont, N., Alyanakian, M., Bach, J., & Chatenoud, L. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00410.x · Cited by 64
Self-citationNew Reagents on the Horizon for Immune Tolerance
Clair, E. W. S., Turka, L. A., Saxon, A., Matthews, J. B., Sayegh, M. H., Eisenbarth, G. S., & Bluestone, J. A. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.58.061705.145449 · Cited by 63
Self-citationAssan, R., Feutren, G., Sirmai, J., Laborie, C., Boîtard, C., Vexiau, P., Rostu, H. D., Roder, M., Pehuet-Figoni, M., Vague, P., et al. (1990) · Diabetes · doi:10.2337/diab.39.7.768 · Cited by 57
SERREZE, D. V., & Silveira, P. A. (2002) · KARGER eBooks · doi:10.1159/000066863 · Cited by 55
Tran, G. T., Carter, N. M., He, X. Y., et al. (2001) · International Immunology · doi:10.1093/intimm/13.9.1109 · Cited by 54
Immune therapies of autoimmune diseases: are we approaching a real cure?
Chatenoud, L. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.09.004 · Cited by 52
Self-citationAntigen-Specific Therapies in Multiple Sclerosis
Sospedra, M., & Martinꝉ, R. (2005) · International Reviews of Immunology · doi:10.1080/08830180500371256 · Cited by 51
Advances in biologic therapy for ulcerative colitis and Crohn’s disease
D’Haens, G., & Daperno, M. (2006) · Current Gastroenterology Reports · doi:10.1007/s11894-006-0041-5 · Cited by 47
YOUNG, D., & Nickerson‐Nutter, C. L. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.03.004 · Cited by 42
Cyclosporin A sensitivity of the NF-χB site of the IL2Rα promoter in untransformed murine T cells
McCaffrey, P. G., Kim, P. K., Valge-archer, V. E., Sen, R., & Rao, A. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.11.2134 · Cited by 42
Co-stimulatory blockade as therapy for rheumatoid arthritis
Mackie, S. L., Vital, E. M. J., Ponchel, F., & Emery, P. (2005) · Current Rheumatology Reports · doi:10.1007/s11926-005-0029-4 · Cited by 12
Cited by
Normalization of obesity-associated insulin resistance through immunotherapy
Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., Dorfman, R., Wang, Y., Zielenski, J., Mastronardi, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2001 · Cited by 1,370
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265
Self-citationType 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine
Haghikia, A., Jörg, S., Duscha, A., Berg, J., Manzel, A., Waschbisch, A., Hammer, A., Lee, D.-H., May, C., Wilck, N., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.007 · Cited by 927
Control of TH17 cells occurs in the small intestine
Esplugues, E., Huber, S., Gagliani, N., Hauser, A. E., Town, T., Wan, Y. Y., O’Connor, W., Rongvaux, A., Van Rooijen, N., Haberman, A. M., et al. (2011) · Nature · doi:10.1038/nature10228 · Cited by 652
Self-citation
Metadata
- Authors
- Chatenoud, L., & Bluestone, J. A.
- Venue
- Nature Reviews Immunology
- Published
- 2007-07-20
- Volume
- 7
- Issue
- 8
- Pages
- 622-632
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2032218738
- Cited by
- 388
- References
- 90
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.